Jorkasky Diane 4

What Happened Diane Jorkasky, a member of Altimmune's board (director), received a grant/award of 48,800 derivative securities on May 1, 2026. The reported acquisition price is $0.00 (a grant of options/awards rather than an open-market purchase or sale). This is an award under the company's non‑employee director compensation policy.

Key Details

• Transaction date: 2026-05-01; Price reported: $0.00 (derivative award).
• Quantity granted: 48,800 shares (derivative/option award).
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Footnotes: (F1) Grant made pursuant to the non‑employee director compensation policy. (F2) The shares underlying the option vest and become exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to continued service.
• Timeliness: Filing lists the transaction date as 2026-05-01 and was filed on 2026-05-01 — no late filing indicated.

Context This was a compensation award to a non‑employee director (not an immediate exercise or sale). The grant vests monthly over the next 12 months and becomes exercisable as portions vest. Director awards are common as part of board compensation and do not by themselves indicate insider buying or selling intent.